New tool aims to stop diabetes before it starts in vulnerable group
NCT ID NCT07264062
Summary
This study is testing a new computer tool called MetSense. It alerts pharmacists when an adult with a serious mental illness (like schizophrenia or bipolar disorder) is at high risk for developing type 2 diabetes. The goal is to see if this alert helps pharmacists provide better preventive care, like ordering blood tests or coordinating with doctors, to stop diabetes before it develops.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
KPNC Division of Research
Pleasanton, California, 94588, United States
Conditions
Explore the condition pages connected to this study.